Memphasys Limited (ASX: MEM) specialises in biological separations for high value commercial applications. The Company's patented membrane processes in combination with electrophoresis, the application of an electrical potential difference across a fluid, enable the separation of high value substances or contaminants from the fluid in which they are contained. The main application of the technology is the separation of the most viable sperm cells for artificial reproduction, most particularly for human IVF.
| Website | http://www.memphasys.com |
| Revenue | $5 million |
| Employees | View employees |
| Address | 30 Richmond Rd, Homebush West, New South Wales 2140, AU |
| Phone | +61 2 8415 7300 |
| Industry | Business Services General, Business Services |
| Competitors | Beckman Coulter Diagnostics, Thermo Fisher Scientific, Merck Group, BD Biosciences, Illumina, Agilent Technologies, Bio-Rad Laboratories, MilliporeSigma, Applied Biosystems Inc., Nexcelom +43 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies |
Looking for a particular Memphasys employee's phone or email?
Memphasys Questions
The Memphasys annual revenue was $5 million in 2026.
Memphasys is based in Homebush West, New South Wales.
The NAICS codes for Memphasys are [5417, 54171, 54, 541713, 541].
The SIC codes for Memphasys are [87, 873].
